JMP Securities raised the firm’s price target on DraftKings (DKNG) to $60 from $50 and keeps an Outperform rating on the shares. DraftKings ...

JMP Securities maintained a Market Outperform rating and a $41.00 price target for Exelixis (NASDAQ:EXEL) shares, aligning with the broader analyst consensus as five analysts have recently revised ...

JMP Securities analyst Devin Ryan raised the firm’s price target on Coinbase (COIN) to $475 from $400 and keeps an Outperform rating on the ...

Angi (NASDAQ:ANGI – Get Free Report) had its price target dropped by investment analysts at JMP Securities from $3.00 to ...

JMP Securities reissued their market outperform rating on shares of CureVac (NASDAQ:CVAC – Free Report) in a report published on Friday,Benzinga reports. JMP Securities currently has a $16.00 price ...

As the US stock markets were catching up with the tech disruption led by cheap Chinese AI models, US President Donald Trump’s ...

At CNBC’s WorldWide Exchange, Zack Kass, an AI futurist and former Head of GTM at OpenAI, discussed the implications of a Chinese firm creating a GPT-4 equivalent model with remarkable efficiency.

Fintel reports that on January 2, 2025, JMP Securities downgraded their outlook ... In its prior filing, the firm reported owning 150,552K shares , representing a decrease of 0.04%.

Fintel reports that on January 2, 2025, JMP Securities downgraded their outlook ... In its prior filing, the firm reported owning 150,552K shares , representing a decrease of 0.04%.

https://www.tipranks.com/news/the-fly/bio-rad-price-target-lowered-to-447-from-477-at-rbc-capital JMP Securities analyst Constantine Davides raised the firm’s price ...

On Wednesday, JMP Securities adjusted its stance on Opportunity (SO:FTCE11B) Financial LLC (NYSE: OPFI), downgrading the stock from Market Outperform to Market Perform. The firm cited the stock's ...